In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 11, 2001, Pages 3276-3278

  Gikas, A ^a   Spyridaki, I ^a   Scoulica, E ^a   Psaroulaki, A ^a   Tselentis, Y ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; LINEZOLID; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; COXIELLA BURNETII; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; Q FEVER; VERO CELL;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CERCOPITHECUS AETHIOPS; CLARITHROMYCIN; COXIELLA BURNETII; DOXYCYCLINE; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; Q FEVER; VERO CELLS;

EID: 0034775875     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.11.3276-3278.2001     Document Type: Article

References (22)

1. Linezolid
2. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalo-sporins
3. Oxazolidinones: A review
4. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin
5. Linezolid and reversible myelosuppression
6. Linezolid, critical characteristics
7. Susceptibility of Rickettsia conori, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin
8. The inhibitory effect of fluoroquinolones on Coxiella burnetii growth in vitro systems
9. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis
10. Optimum treatment of intracellular infection
11. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: The Coxiella burnetii paradigm
12. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin
13. Antibiotic treatment of rickettsiosis, recent advances and current concepts
14. Shell-vial assay: Evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii
15. Treatment of Q fever
16. Q fever in the Greek island of Crete: Detection, isolation, and molecular identification of eight strains of Coxiella burnetii from clinical samples
17. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria
18. In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay
19. Q fever in the Greek island of Crete: Epidemiologic, clinical, and therapeutic data from 98 cases
20. The in vitro activity of linezolid (U-100766) and tentative breakpoints
21. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones